A. Linn Murphree, MD
Professor of Ophthalmology
and Pediatrics
Request an Appointment
Doheny Eye Center, Los Angeles
1450 San Pablo Street,
Los Angeles, CA 90033
(323) 442-6522
Doheny Eye Center, Los Angeles
1450 San Pablo Street,
Los Angeles, CA 90033
(323) 442-6522
The Vision Center
Childrens Hospital Los Angeles
4650 Sunset Blvd.
Los Angeles, CA 90027
(323) 361-2347
Childrens Hospital Los Angeles
4650 Sunset Blvd.
Los Angeles, CA 90027
(323) 361-2347
Clinical Specialties
Ocular Oncology
Retinoblastoma
Chorodial Melanoma
Academic Degrees
American Academy of Ophthalmology
American Academy of Pediatrics
Pan American Association of Ophthalmology
Association for Research in Vision and Ophthalmology
Society of Heed Fellows
Ocular Oncology
Retinoblastoma
Chorodial Melanoma
Academic Degrees
American Academy of Ophthalmology
American Academy of Pediatrics
Pan American Association of Ophthalmology
Association for Research in Vision and Ophthalmology
Society of Heed Fellows
Residency
Baylor College of Medicine, 1973 - 1976, Ophthalmology
Baylor College of Medicine, 1973 - 1976, Ophthalmology
Fellowships
Medical Genetics, Bayor College of Medicine, 1972-1973
Ophthalmic Genetics, Wilmer Ophthalmological Institute, Johns Hopkins Hospital
Board Certification
American Board of Ophthalmology
American Board of Ophthalmology
Research Activities
Dr. Murphree’s research group was one of two groups to clone the retinolbastoma gene, the first human cancer gene to be identified.
He developed the international classification system for grouping intraocular retinoblastoma that is now in general use.
Dr. Murphree holds several patents. One of his inventions, the RetCam®, is a digital hand-held wide-angle retinal imaging system currently used in neonatal intensive care units and in operating rooms around the world for the diagnosis and documentation of both retinopathy of prematurity and retinoblastoma.
His current research focuses on improved methods to develop therapy for intraocular tumors directly to the eye.
Dr. Murphree currently limits his practice to choroidal melanomas in adults and retinoblastoma in children. He consults internationally on issues of ocular oncology.
Dr. Murphree’s research group was one of two groups to clone the retinolbastoma gene, the first human cancer gene to be identified.
He developed the international classification system for grouping intraocular retinoblastoma that is now in general use.
Dr. Murphree holds several patents. One of his inventions, the RetCam®, is a digital hand-held wide-angle retinal imaging system currently used in neonatal intensive care units and in operating rooms around the world for the diagnosis and documentation of both retinopathy of prematurity and retinoblastoma.
His current research focuses on improved methods to develop therapy for intraocular tumors directly to the eye.
Dr. Murphree currently limits his practice to choroidal melanomas in adults and retinoblastoma in children. He consults internationally on issues of ocular oncology.